Leila A Haidari1, Shawn T Brown1, Dagna Constenla2, Eli Zenkov1, Marie Ferguson2, Gatien de Broucker2, Sachiko Ozawa2, Samantha Clark2, Bruce Y Lee3. 1. Pittsburgh Supercomputing Center (PSC), Carnegie Mellon University, Pittsburgh, PA, United States. 2. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States. 3. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; Public Health Computational and Operations Research (PHICOR), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States. Electronic address: brucelee@jhu.edu.
Abstract
BACKGROUND: With tetanus being a leading cause of maternal and neonatal morbidity and mortality in low and middle income countries, ensuring that pregnant women have geographic access to tetanus toxoid (TT) immunization can be important. However, immunization locations in many systems may not be placed to optimize access across the population. Issues of access must be addressed for vaccines such as TT to reach their full potential. METHODS: To assess how TT immunization locations meet population demand in Mozambique, our team developed and utilized SIGMA (Strategic Integrated Geo-temporal Mapping Application) to quantify how many pregnant women are reachable by existing TT immunization locations, how many cannot access these locations, and the potential costs and disease burden of not covering geographically harder-to-reach populations. Sensitivity analyses covered a range of catchment area sizes to include realistic travel distances and to determine the area some locations would need to cover in order for the existing system to reach at least 99% of the target population. RESULTS: For 99% of the population to reach health centers, people would be required to travel up to 35km. Limiting this distance to 15km would result in 5450 (3033-7108) annual cases of neonatal tetanus that could be prevented by TT, 144,240 (79,878-192,866) DALYs, and $110,691,979 ($56,180,326-$159,516,629) in treatment costs and productivity losses. A catchment area radius of 5km would lead to 17,841 (9929-23,271) annual cases of neonatal tetanus that could be prevented by TT, resulting in 472,234 (261,517-631,432) DALYs and $362,399,320 ($183,931,229-$522,248,480) in treatment costs and productivity losses. CONCLUSION: TT immunization locations are not geographically accessible by a significant proportion of pregnant women, resulting in substantial healthcare and productivity costs that could potentially be averted by adding or reconfiguring TT immunization locations. The resulting cost savings of covering these harder to reach populations could help pay for establishing additional immunization locations.
BACKGROUND: With tetanus being a leading cause of maternal and neonatal morbidity and mortality in low and middle income countries, ensuring that pregnant women have geographic access to tetanus toxoid (TT) immunization can be important. However, immunization locations in many systems may not be placed to optimize access across the population. Issues of access must be addressed for vaccines such as TT to reach their full potential. METHODS: To assess how TT immunization locations meet population demand in Mozambique, our team developed and utilized SIGMA (Strategic Integrated Geo-temporal Mapping Application) to quantify how many pregnant women are reachable by existing TT immunization locations, how many cannot access these locations, and the potential costs and disease burden of not covering geographically harder-to-reach populations. Sensitivity analyses covered a range of catchment area sizes to include realistic travel distances and to determine the area some locations would need to cover in order for the existing system to reach at least 99% of the target population. RESULTS: For 99% of the population to reach health centers, people would be required to travel up to 35km. Limiting this distance to 15km would result in 5450 (3033-7108) annual cases of neonatal tetanus that could be prevented by TT, 144,240 (79,878-192,866) DALYs, and $110,691,979 ($56,180,326-$159,516,629) in treatment costs and productivity losses. A catchment area radius of 5km would lead to 17,841 (9929-23,271) annual cases of neonatal tetanus that could be prevented by TT, resulting in 472,234 (261,517-631,432) DALYs and $362,399,320 ($183,931,229-$522,248,480) in treatment costs and productivity losses. CONCLUSION: TT immunization locations are not geographically accessible by a significant proportion of pregnant women, resulting in substantial healthcare and productivity costs that could potentially be averted by adding or reconfiguring TT immunization locations. The resulting cost savings of covering these harder to reach populations could help pay for establishing additional immunization locations.
Authors: Mohammad Naeem; Muhammad Zia-ul-Islam Khan; Syed Hussain Abbas; Muhammad Adil; Ayasha Khan; Syeda Maria Naz; Muhammad Usman Khan Journal: J Ayub Med Coll Abbottabad Date: 2010 Jul-Sep
Authors: Ulla K Griffiths; Lara J Wolfson; Arshad Quddus; Mohammed Younus; Rehan A Hafiz Journal: Bull World Health Organ Date: 2004-09 Impact factor: 9.408
Authors: Demócrito B Miranda-Filho; Ricardo A A Ximenes; Noêmia T Siqueira-Filha; Andreia C Santos Journal: Trop Med Int Health Date: 2013-03-05 Impact factor: 2.622
Authors: Bruce Y Lee; Shawn T Brown; Leila A Haidari; Samantha Clark; Taiwo Abimbola; Sarah E Pallas; Aaron S Wallace; Elizabeth A Mitgang; Jim Leonard; Sarah M Bartsch; Tatenda T Yemeke; Eli Zenkov; Sachiko Ozawa Journal: Vaccine Date: 2019-03-25 Impact factor: 3.641
Authors: Leila A Haidari; Shawn T Brown; Dagna Constenla; Eli Zenkov; Marie Ferguson; Gatien de Broucker; Sachiko Ozawa; Samantha Clark; Allison Portnoy; Bruce Y Lee Journal: Sex Transm Dis Date: 2017-04 Impact factor: 2.830
Authors: Joseph Maina; Paul O Ouma; Peter M Macharia; Victor A Alegana; Benard Mitto; Ibrahima Socé Fall; Abdisalan M Noor; Robert W Snow; Emelda A Okiro Journal: Sci Data Date: 2019-07-25 Impact factor: 6.444